Objective: Personal Digital Assistants (PDAs) have the potential to improve clinical trial data collection; however, most current PDA-based clinical data collection systems typically collect and store data in the offline mode, and then transfer the data to an operational database. The purpose of this study was to explore the usefulness of a wireless clinical data collection system for an irritable bowel syndrome trial compared with the traditional paper based data collection. Methods: We have developed a PDA-based data capture system for clinical trials, and tested it in a double-blind trial. Sixty four patients with irritable bowel syndrome were randomly selected and divided into a control group that used the standard paper report forms (CRF) and an intervention group that used the electronic report forms (e-CRF), daily for five weeks. There were 630 data sets consisting of six questions each, and thus 3,570 data points total were collected. Results: The response rate of the control group was significantly higher than that of the intervention group. However, the completeness of the response in the intervention group was higher and the number of input errors per person for the PDA group was lower than in the paper group. Conclusion: A PDA based electronic diary improved the response rate and decreased input errors in an IBS trial. We conclude that mobile devices can be very useful, especially when the proposed design and connectivity aspects have been taken into account. (Journal of Korean Society of Medical Informatics 15-2, [235][236][237][238][239][240][241][242][243][244] 2009) 
I. Introduction
Clinical trials are the most expensive and time consuming steps in drug development. In a paper-based clinical trial process, a Case Report Form (CRF), which is data collection form, typically has three or four copies per page, and the monitoring is typically done by hand at the investigative site comparing the CRF with source documents. The CRF data are later entered twice at a central location into a database. Information technology has been used to support clinical trials to have the most immediate and noticeable impact on drug development.
Clinical trial technology that has been applied to improve clinical trial data collections is generally referred to as electronic data capture (EDC). The benefits of EDC include direct data entry at the investigator site leading to greater accuracy, fewer queries, decreased paper record storage, and timelier population of the study database 1) . Although increasing in pace, the conversion to EDC has been a slow progression 2) . A survey . However, wired internet needs to connect the computer to the location where the Internet connection is available. Recently, mobile computing technology is proposed to improve information access, enhance workflow, and promote evidence-based practice to make informed and effective decisions at any place and any time. Mobile devices have been used in clinical trials for more than 16 years, utilizing different technologies. These devices have been used in different medical fields such as diabetes 6) 7) , nutrition 8) , different surveys 9) . The mobile technology capable of data capture or data entry becomes employed in clinical trials. The variety of applications in clinical trials ranges from electronic patient diaries [10] [11] [12] to electronic case report forms (eCRFs) 13)14) . 18) . In Korea, mobile internet subscribers exceeded 30 million, about 70% of the population by 2002 19) . The mobile internet is generally used data communication network for everyday life such as mobile shopping, mobile banking, and mobile advertising in Korea. In spite of spreading mobile technology in Korea, data collection in clinical trial studies has still done on paper first and sometimes with electronic data entry taking place later. Furthermore, even few PDA-based clinical data collection systems typically collect and store data in offline mode, and then synchronize with the server by transferring to the operational database. Also, data review, data quality checks, and monitoring were performed manually and locally at the site. Real time data collection and transmit through mobile internet connection is still challenging area.
In response to these challenges, we have developed a wireless PDA application that patients can use both to evaluate their experience with a drug and to directly transmit their data to a database using a wireless internet connection. We used PDA instead of paper patient diaries in a randomized, placebo-controlled, doubleblind irritable bowel syndrome (IBS) trial. IBS, a functional gastrointestinal disorder, rely exclusively on patients' self reports of their symptoms 20) .
The purpose of this study is to determine the im- 
II. Materials and Methods
A randomized double-blind study was carried out to Table 1 .
Research coordinators gained the informed consent and enter patients' basic information into the system at the beginning. Both forms are completed once daily at home for five weeks. . A chi-square test was conducted to compare response rates and response completeness between the two groups. Additionally, the Mantel-Haenszel chisquare test was applied to identify the influence of data collection methods on response completeness controlling demographic variables. Finally, the number of input errors and protocol compliance were measured.
Protocol compliance means that both groups should enter their medication intakes during five weeks at five measurement periods on a paper or a PDA form.
Subjects usually report that they fill out the survey form following the protocol. However, subjects usually forget to write down the form at the exact time. This study compared the reported compliance and actual compliance. Table 2 . Reason for withdrawal of participants
System architecture
Our data collection system is comprised of two components: a) a web application for internal users and subjects; and b) PDA application composed of an administrator module and a subject module Web application (Fig. 2) .
The web application was developed with Active Server Page (ASP) and Javascript. MS SQL Server was used as database. The web application was divided by two parts by the types of users: such as administrators or coordinators, and subjects. Application for internal users has Active Sync 3.1 program to synchronize the PDA application with the desktop application.
Authenticated users can then update and edit data through any web browser, which permits a reliable and wireless internet access.
Coordinators can enroll eligible subjects and check the entered data, add new subjects, modify and review information for registered subjects, and review the status of the current study. They are also able to enter and revise demographic information and make inquiries about all entered information through PDAs or desktop.
Administrators are able to enter and manage patient information and assign appropriate privilege to study personnel, thus allowing management of subjects and information. They can also check for redundant identi- connection. Figure 3 shows the log-in screen and input screen for the PDA application.
III. Results
Sixty four patients initially enrolled to participate, but twenty eight patients withdrew for the following reasons suggested by Table 2 .
Demographic characteristics
The sample for this study consisted of 18 patients (50%) for control and 18 patients (50%) for intervention; 19 (53%) were women, and 17 (47%) were The demographic characteristics of the participants are summarized in Table 1 . The two groups did not have any significant demographic differences, except age. Age between the two groups shows statistically significant difference. The age of the control group was much higher than the intervention group (p<0.0001).
These significant age differences can make selection bias. To control selection bias, patients in the common age range should be retested. The common age range is 40 to 45 years. However, there are only four patients in the intervention group and five patients in the control group within this age range. Thus, additional analysis cannot be conducted because the sample size is too small. And, disease duration of control group and intervention group is 4.1 and 6.2 year respectively. However, it doesn't show statistical difference (Table 3) . Table 6 ). This result shows Sex, Age and disease duration has significant relationship with the use of PDA for data collection.
Response rate

Input error
In the control group, 11 subjects committed 78 cases of input error, whereas in the intervention group, 14 subjects committed 52 cases of input error. Additionally, the characteristics of the errors were different across the two groups. The major errors in the control group were duplicate answers in a question. By contrast, the errors in the intervention group were functional errors, like pushing the wrong button or the same button twice causing unwanted double entry in a day.
As subjects become proficient with the PDA, errors are expected to decrease. Nonetheless, the input error per person for the PDA group (4 cases) was lower than that for the paper group (7 cases) ( Table 7) .
Protocol compliance
Protocol compliance means that both groups should enter their medication intakes during five weeks at five measurement periods on a paper or a PDA form. 95.2%
of the control group reported that they answered the questionnaires according to the direction during first through second weeks, however, only 73.4% followed up the direction correctly. On the other hand, since PDA group transmit data as soon as items are answered, reported and actual response rate are identical as 84.1%. The compliance rate for 1-2 weeks of the intervention group is higher than the control group (Table 8) .
In third through fourth weeks, 94.4% of the control group reported to follow up the diction, however only 67.2 % actually answered correctly, Thus, the protocol compliance rate for 3-4 weeks of the intervention group is also higher than the control group as 78.6% (Table   8 ).
IV. Discussion
This study addresses whether wireless PDA technology can reduce clinical data input error and improve response rate, data quality and protocol compliance.
Average age choosing PDA group is much lower than non-PDA group. Higher preference for PDA of younger generation is likely due to their equal familiarity with mobile phone. As mobile phones continue to become integrated into their daily lives, mobile EDC preference among patients may continue to grow.
In spite of participants' preference, the response rate was lower than paper group. We assume that current PDA technology is not stable and reliable to use for
clinical trials yet based on our supplementary survey.
The survey regarding the PDA usage shows that few users become disgruntled and complained some difficulties of PDA data entry. Out of 21 respondents, 66%
of them showed the difficulty of PDA usages, and 33%
had unstable internet access. To apply PDA for clinical data collection, these technical issues should be resolved soon.
Our finding also supports previous literature reporting that PDA can enhance completeness of data collection 21) . Lower number of the missed items was found in the PDA collection compared with paper method. This increased data collection has a direct beneficial impact on the quality of data collected.
Regarding to input errors, PDA is supposed to have error free data collection compared with paper. However, PDA collection still has input errors. The errors were functional errors, like pushing the wrong button or the same button twice. Therefore, predesigned functions alerting users before developing e-CRF application will be able to reduce possible errors. Electronic data entry will not result in error-free data collection without built in check functions. Minimizing the data entry errors that result from extra data entry steps will streamline the data clean-up stage of clinical trials.
In spite of few errors, the quality of data in PDA is improved in comparison to paper group because the data are more complete, have fewer errors, and there are fewer protocol violations like other studies 14) [22] [23] [24] .
Thus, data editing, retyping, proofreading, and the process of clarification can be eliminated, and irrelevant questions can be omitted.
Also, protocol compliance was comparably improved.
Significant retrospective entries were made in the con- However, wide adoption of PDA technology is expected with better designed PDA hardware and software applications, faster internet access, improved battery life, seamless integration of PDA technology with hospital information systems, and satisfactory security measures.
Herein, we described some barriers and benefits based on our experience to collect clinical trial data. We desire it will give you some idea on how to successfully implement PDA based data capture system in your organization. The results of this study confirm the feasibility and adaptability of the data capture through PDA administered questionnaires. Analysis of data completeness, response rate, and protocol compliance suggest that the IBS questionnaires can be maintained under PDA application.
